CRISPR

Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
UC Berkeley News
Wed, 05/14/25 - 09:59 am
legal
patents
Berkeley
CRISPR
gene editing
CRISPR Therapeutics sees 80% fall in LDL, triglycerides after in vivo liver editing
Fierce Biotech
Wed, 05/7/25 - 11:23 am
CRISPR Therapeutics
CRISPR
gene editing
CTX310
LDL cholesterol
Caribou, in reversal, scraps autoimmune cell therapy and cuts staff
BioPharma Dive
Fri, 04/25/25 - 11:19 am
Caribou Biosciences
CRISPR
layoffs
lupus
cancer
cell therapy
CRISPR Therapeutics COO Departure Announced Following 7% Share Price Decline
Yahoo Finance
Fri, 03/28/25 - 11:18 am
CRISPR Therapeutics
Julianne Bruno
CRISPR
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
BioPharma Dive
Mon, 03/10/25 - 11:17 pm
Beam Therapeutics
base editing
alpha-1 antitrypsin deficiency
CRISPR
CRISPR’s cardio catch-all drives a biotech’s broad potential
Pharma Voice
Tue, 02/18/25 - 09:53 am
Scribe Therapeutics
CRISPR
cardiovascular disease
Why CRISPR Therapeutics Stock Was a Massive Winner on Wednesday
Motley Fool
Wed, 02/12/25 - 09:36 pm
CRISPR Therapeutics
CRISPR
earnings
Scribe slims down workforce as it readies cardiometabolic genetic meds for clinic
Fierce Biotech
Wed, 01/8/25 - 11:14 pm
Scribe Therapeutics
cardiometabolic diseases
CRISPR
Beam hits hemoglobin goal in first base editing clinical data, reports death tied to conditioning drug
Fierce Biotech
Tue, 11/5/24 - 10:05 am
Beam Therapeutics
clinical trials
sickle cell disease
CRISPR
base editing
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks in phase 2
Fierce Biotech
Thu, 10/24/24 - 09:58 am
Intellia Therapeutics
CRISPR
HAE
NTLA-2002
Editas, changing course again, looks to partner lead CRISPR therapy
BioPharma Dive
Tue, 10/22/24 - 11:45 am
Editas Medicine
gene editing
CRISPR
reni-cel
sickle cell disease
beta thalassemia
Vertex taps Lonza to help produce global supply of cutting-edge CRISPR therapy Casgevy
Fierce Pharma
Tue, 09/24/24 - 09:51 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Lonza
Casgevy
Illumina, CRISPR-pioneer Broad Institute to work on new gene sequencing kits
Reuters
Tue, 08/13/24 - 11:01 pm
Illumina
Medtech
Broad Institute
CRISPR
gene sequencing
Vertex sues U.S. government over access to fertility support services for Casgevy patients
Stat
Mon, 07/15/24 - 11:13 pm
Vertex Pharmaceuticals
Fertility
CRISPR
Casgevy
First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
BioPharma Dive
Wed, 06/26/24 - 10:00 am
Intellia Therapeutics
CRISPR
gene editing
transthyretin amyloidosis
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive
Thu, 04/25/24 - 11:31 am
Regeneron
Mammoth Biosciences
CRISPR
gene editing
Vertex Fails to Convince UK Watchdog of CRISPR Therapy Casgevy’s Value
BioSpace
Thu, 03/14/24 - 06:19 pm
Vertex Pharmaceuticals
UK
sickle cell disease
CRISPR
Casgevy
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
BioSpace
Wed, 03/13/24 - 10:39 am
Ricoh
ERS Genomics
gene editing
CRISPR
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia’s CRISPR drug could offer one-shot HAE treatment
Pharmaphorum
Thu, 02/1/24 - 11:26 am
Intellia Therapeutics
HAE
clinical trials
CRISPR
gene editing
NTLA-2002

Pages